Literature DB >> 25762035

False-positive (13)N-ammonia/(18)FDG PET for evaluation of cardiac sarcoidosis in a patient on peritoneal dialysis.

Waddy O Gonzalez1,2, Daniele Massera2, Mark I Travin3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25762035     DOI： 10.1007/s12350-015-0092-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  3 in total

Review 1.  The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis.

Authors:  B A Mc Ardle; E Leung; H Ohira; M S Cocker; R A deKemp; J DaSilva; D Birnie; R S Beanlands; P B Nery
Journal:  J Nucl Cardiol       Date:  2013-01-04       Impact factor: 5.952

2.  Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations.

Authors:  A Perry; F Vuitch
Journal:  Arch Pathol Lab Med       Date:  1995-02       Impact factor: 5.534

3.  Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.

Authors:  Michael T Osborne; Edward A Hulten; Avinainder Singh; Alfonso H Waller; Marcio S Bittencourt; Garrick C Stewart; Jon Hainer; Venkatesh L Murthy; Hicham Skali; Sharmila Dorbala; Marcelo F Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2013-12-03       Impact factor: 5.952
  3 in total
  1 in total

1.  2020 vision: New insights on hypoxia imaging to assess cardiac and extra-cardiac active inflammatory sarcoidosis.

Authors:  Ronald G Schwartz; Himabindu Vidula
Journal:  J Nucl Cardiol       Date:  2020-02-07       Impact factor: 5.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.